MedPath

Amphotericin B

Amphotericin B Liposome for Injection Rx only

Approved
Approval ID

593cffa0-c305-48b6-8ec7-331e0ff91d2b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2022

Manufacturers
FDA

Sun Pharmaceutical Industries, Inc.

DUNS: 146974886

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Amphotericin B

PRODUCT DETAILS

NDC Product Code62756-233
Application NumberANDA212514
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateFebruary 9, 2022
Generic NameAmphotericin B

INGREDIENTS (1)

AMPHOTERICIN BActive
Quantity: 50 mg in 1 1
Code: 7XU7A7DROE
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Amphotericin B - FDA Drug Approval Details